(Q43996616)

28 November 2017

title

Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation (English)

1 reference

28 November 2017

0 references

1 reference

Kam S Woo

1

1 reference

28 November 2017

Ping Chook

2

1 reference

28 November 2017

Lindy L T Chan

3

1 reference

28 November 2017

Alice S P Cheung

4

1 reference

28 November 2017

Wing H Fung

5

1 reference

28 November 2017

M u Qiao

6

1 reference

28 November 2017

Yvette I Lolin

7

1 reference

28 November 2017

G N Thomas

8

1 reference

28 November 2017

John E Sanderson

9

1 reference

28 November 2017

Con Metreweli

10

1 reference

28 November 2017

David S Celermajer

11

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

American Journal of Medicine

28 November 2017

published in

1 reference

28 November 2017

volume

112

1 reference

28 November 2017

issue

7

1 reference

28 November 2017

page(s)

535-539

1 reference

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Hyperhomocysteinemia: an independent risk factor for vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Homocysteine, oxidative stress, and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Homocysteine and coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Close relation of endothelial function in the human coronary and peripheral circulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

A sharper Bonferroni procedure for multiple tests of significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Homocysteine and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Is NO an endogenous antiatherogenic molecule?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Homocystinemia. Vascular injury and arterial thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Homocysteine catabolism: levels of 3 enzymes in cultured human vascular endothelium and their relevance to vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Stimulation of endothelial nitric oxide production by homocyst(e)ine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Effects of Oral Folic Acid Supplementation on Endothelial Function in Familial Hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901075-6

10.1016/S0002-9343(02)01075-6

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference